ATF3 and neoplasm: Over the last few years, many studies have aroused an interest in activating transcription factor 3 (ATF3) as a novel tumor suppressor mediator in glioblastoma, as well as colon, lung, bladder, and cervical cancer cells and its possible therapeutic applications [6–10].